GO:0061844 antimicrobial humoral immune response mediated by antimicrobial peptide: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061844 describes the branch of humoral immunity in which antimicrobial peptides (AMPs) secreted into body fluids directly neutralize or kill microbes.
• AMPs such as defensins, cathelicidins and bactenecins are the effector molecules of this process and act against bacteria, fungi, enveloped viruses and protozoa.
• The process is evolutionarily ancient and is conserved from insects to teleost fish to mammals, making model organisms highly informative.
• Neutrophils, epithelial cells and other innate immune cells are the principal sources of AMPs in body fluids.
• Dysregulation of AMP-mediated humoral immunity contributes to allergic airway disease, mycobacterial infection control and HIV-1 restriction.
• CRISPR knockout, knock-in, point-mutation and overexpression models are powerful tools to dissect the causal role of individual AMP genes in this GO term.
Description
Antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844) is the biological process in which anti-microbial peptides (AMPs) present in body fluids provide humoral protection against microbes. Unlike antibody-mediated humoral immunity, this process does not require B cells or immunoglobulins; instead, small cationic or amphipathic peptides secreted by innate immune cells and epithelia act directly on microbial membranes and intracellular targets. The term is therefore a core node of innate humoral immunity and is studied across immunology, infection biology and comparative immunology. The importance of GO:0061844 for researchers lies in its dual role as a first-line defense and as a modulator of adaptive immunity. AMPs such as beta-defensins and bactenecins are induced rapidly upon microbial challenge, and their activity shapes the outcome of bacterial, fungal and viral infections. In parallel, AMPs influence neutrophil recruitment and inflammatory signaling, linking this GO term to allergic and chronic inflammatory diseases. Because AMPs are secreted rather than cell-bound, the process is experimentally tractable through body-fluid assays, making it an attractive target for functional genomics. This article integrates the QuickGO definition of GO:0061844 with verified PubMed literature to summarize the mechanism, key genes, disease relevance and CRISPR-based research strategies for this process.
antimicrobial humoral immune response mediated by antimicrobial peptide At A Glance
| GO ID | GO:0061844 |
|---|---|
| GO term | antimicrobial humoral immune response mediated by antimicrobial peptide |
| Ontology | biological_process |
| Synonym | antimicrobial peptide-mediated antimicrobial humoral response; peptide-mediated antimicrobial humoral response |
| Major function | Humoral immune defense against microbes mediated by secreted antimicrobial peptides in body fluids |
| Effector molecules | Antimicrobial peptides including defensins, cathelicidins and bactenecins |
| Cellular sources | Neutrophils, epithelial cells and other innate immune cells |
| Target microbes | Bacteria, fungi, enveloped viruses and protozoa |
| Conservation | Present in insects, teleost fish and mammals |
What Is GO:0061844?
GO:0061844 is defined by QuickGO as an immune response against microbes mediated by anti-microbial peptides in body fluid. In other words, it is the humoral arm of innate immunity in which soluble AMPs, rather than antibodies, are the effector molecules that recognize and neutralize microbial threats. The process encompasses the production, secretion and antimicrobial action of these peptides in fluids such as mucus, plasma and tissue exudates.
Why Is antimicrobial humoral immune response mediated by antimicrobial peptide Important in Cell Biology?
GO:0061844 is important because it represents a fast, antibody-independent defense system that operates at mucosal surfaces and in circulation, and its dysfunction is linked to infection susceptibility, chronic inflammation and allergic disease. Understanding this process informs vaccine design, anti-infective drug development and the interpretation of innate immune signatures in human disease.
• Provides first-line humoral defense against bacteria, fungi and enveloped viruses before adaptive immunity is engaged.
• AMPs such as beta-defensins are conserved across vertebrates, enabling comparative studies in teleost models.
• Neutrophil-derived AMPs are upregulated during the progression from allergic rhinitis to asthma.
• Bactenecin 5 supports cell-mediated but not humoral immunity in mycobacterial vaccine models, revealing context-dependent roles.
• Insect Toll signaling activates cellular immune responses via eicosanoids, showing evolutionary links to AMP-based humoral immunity.
• Innate immunity-related genes in insects include AMP effectors that are core to this GO term.
• Drosophila ubiquitin signaling regulates innate immune responses, including AMP production.
• Soluble mediators of anti-fungal immunity include AMPs that act in body fluids.
• HIV-1 restriction by innate immune factors includes AMP-mediated mechanisms.
• CRISPR models allow causal testing of individual AMP genes in this process.
What Happens During antimicrobial humoral immune response mediated by antimicrobial peptide?
Microbial recognition and AMP induction
In simple terms: When microbes are detected, immune cells switch on genes that make antimicrobial peptides.
Microbial recognition by innate immune receptors triggers signaling cascades that induce AMP gene expression. In Drosophila, Toll signaling activates cellular immune responses via eicosanoids, and ubiquitin signaling modulates these innate immune outputs. In insects, innate immunity-related genes including AMP effectors are coordinately regulated. In mammals, neutrophil-driven antimicrobial immune responses are upregulated during allergic airway disease progression, indicating that AMP induction is tightly linked to inflammatory context.
Secretion of AMPs into body fluids
In simple terms: The peptides are released into mucus, plasma and tissue fluids where they can meet microbes.
AMPs are secreted by neutrophils, epithelial cells and other innate immune cells into body fluids, where they constitute soluble mediators of anti-fungal and antibacterial immunity. Beta-defensins in teleost fish are secreted into mucosal fluids and act as adroit saviours against pathogens. The soluble nature of these mediators distinguishes GO:0061844 from cell-mediated immunity and enables body-fluid-based experimental assays.
Direct antimicrobial action
In simple terms: The peptides attach to and disrupt microbes, killing or neutralizing them.
Secreted AMPs such as bactenecin 5 and beta-defensins directly act on microbial targets. Bactenecin 5 supports cell-mediated but not humoral immunity in a mycobacterial antigen vaccine model, illustrating that AMP activity can be context-dependent. Soluble mediators in anti-fungal immunity include AMPs that damage fungal cells. Innate immune response against HIV-1 involves AMP-mediated restriction mechanisms.
Integration with other immune arms
In simple terms: AMP-based humoral immunity works together with cellular immunity and inflammation.
GO:0061844 does not operate in isolation; it intersects with cell-mediated immunity and inflammatory signaling. Bactenecin 5 supports cell-mediated but not humoral immunity in a vaccine model, showing functional cross-talk. Neutrophil-mediated antimicrobial responses are upregulated in the development from allergic rhinitis to asthma, linking AMP humoral immunity to type 2 inflammation. Toll and ubiquitin signaling pathways in Drosophila integrate AMP production with cellular immune effectors.
Key Genes Involved in GO:0061844 antimicrobial humoral immune response mediated by antimicrobial peptide
The following genes and gene families encode the principal AMP effectors and regulators of GO:0061844 across model organisms and humans.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DEFB4A | Beta-defensin 4A, an antimicrobial peptide secreted into body fluids | Teleost and mammalian models of mucosal defense |
| DEFB1 | Beta-defensin 1, epithelial AMP | Barrier immunity and infection studies |
| CAMP | Cathelicidin LL-37, neutrophil and epithelial AMP | Neutrophil-driven antimicrobial responses |
| CATHL | Cathelicidin family in teleosts | Comparative AMP immunity in fish |
| Bactenecin 5 (BAC5) | Bovine neutrophil AMP | Vaccine and mycobacterial immunity models |
| Drosomycin | Drosophila antifungal AMP | Toll signaling and innate immunity |
| Defensin (Drosophila) | Insect AMP effector | Insect innate immunity gene networks |
| Cecropin | Insect antibacterial AMP | Toll and eicosanoid signaling studies |
| Attacin | Insect antibacterial AMP | Innate immunity gene regulation |
| Toll | Receptor activating AMP gene expression | Drosophila innate immune signaling |
| MyD88 | Adapter in Toll/IL-1 signaling for AMP induction | Conserved AMP induction pathways |
| NF-kB (Relish) | Transcription factor driving AMP genes | Insect and mammalian AMP regulation |
| Ubiquitin pathway genes | Regulate Drosophila innate immune responses | Post-translational control of AMP immunity |
| Eicosanoid pathway genes | Activate cellular immune response downstream of Toll | Insect immunity integration |
| IL-1 family cytokines | Amplify neutrophil AMP responses | Allergic airway disease models |
| S100A8/A9 | Neutrophil-derived antimicrobial proteins | Neutrophil antimicrobial response studies |
| Lactoferrin | Iron-sequestering AMP in body fluids | Soluble anti-fungal and antibacterial immunity |
| Lysozyme | Enzymatic AMP in secretions | Humoral innate immunity assays |
How Is antimicrobial humoral immune response mediated by antimicrobial peptide Regulated?
GO:0061844 is regulated at multiple levels. Transcriptionally, Toll and NF-kB signaling induce AMP gene expression in insects and mammals. Post-translationally, ubiquitin signaling modulates Drosophila innate immune responses, affecting AMP output. Eicosanoid signaling downstream of Toll activates cellular immune responses that integrate with AMP-based humoral immunity. In mammals, neutrophil recruitment and inflammatory cytokines such as IL-1 family members amplify AMP secretion during allergic airway disease progression. Soluble mediators of anti-fungal immunity are also regulated by the microbial environment and host nutritional status.
antimicrobial humoral immune response mediated by antimicrobial peptide and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAMP | Allergic airway inflammation | Knockout mouse or human airway epithelial KO |
| BAC5 | Mycobacterial vaccine immunity | Overexpression in bovine or murine cells |
| DEFB4A | Mucosal infection susceptibility | Teleost knock-in or KO |
| Toll/MyD88 | Innate immune deficiency | Drosophila KO and point mutation |
| Ubiquitin pathway genes | Innate immune dysregulation | Drosophila KO and tagged knock-in |
Allergic rhinitis and asthma
Upregulated antimicrobial immune responses mediated by neutrophils are observed in the development from allergic rhinitis to asthma, suggesting that AMP-driven humoral immunity contributes to airway inflammation. This links GO:0061844 to chronic allergic disease pathogenesis.
Mycobacterial infection and vaccine response
Bactenecin 5, an antimicrobial peptide, supports cell-mediated but not humoral immunity in the context of a mycobacterial antigen vaccine model, indicating that AMPs can shape vaccine-induced immunity in tuberculosis research.
HIV-1 infection
Innate immune responses against HIV-1 include AMP-mediated mechanisms, and soluble mediators contribute to viral restriction. This positions GO:0061844 within antiviral innate immunity.
Fungal infection
Soluble mediators in anti-fungal immunity include antimicrobial peptides that act in body fluids, highlighting the role of GO:0061844 in defense against fungal pathogens.
From antimicrobial humoral immune response mediated by antimicrobial peptide-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a specific AMP gene required for microbial killing? | CRISPR knockout in epithelial or neutrophil-like cells |
| Does a point mutation alter AMP activity? | CRISPR point mutation knock-in |
| Can AMP expression be tracked in vivo? | Tagged knock-in of AMP gene |
| Does AMP overexpression enhance protection? | CRISPR overexpression or lentiviral overexpression |
| Which signaling genes regulate AMP induction? | Knockout of Toll/MyD88/NF-kB in Drosophila |
| How do AMPs integrate with cellular immunity? | Co-culture KO models and eicosanoid pathway mutants |
How to Study the antimicrobial humoral immune response mediated by antimicrobial peptide Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | AMP gene expression changes | Infection and inflammation models |
| qPCR | Specific AMP transcript levels | Validation of induction |
| Antimicrobial killing assay | Microbial survival after AMP exposure | Functional AMP testing |
| CRISPR knockout | Loss-of-function of AMP or regulator | Causal gene testing |
| CRISPR knock-in | Tagged or mutant AMP expression | Localization and activity studies |
| Overexpression | Gain-of-function of AMP | Protection and vaccine models |
| Drosophila genetics | In vivo AMP regulation | Toll and ubiquitin signaling |
| Teleost infection models | Mucosal AMP defense | Beta-defensin studies |
Transcriptomic profiling of AMP genes
RNA-seq and qPCR are used to measure AMP gene induction after microbial challenge or inflammatory stimulation. In insects, innate immunity-related gene panels including AMPs are profiled to define regulatory networks. In allergic airway disease, neutrophil-associated antimicrobial gene signatures are detected by transcriptomics.
Antimicrobial activity assays
Body fluids or recombinant AMPs are tested against bacteria and fungi in killing assays. Bactenecin 5 activity has been evaluated in mycobacterial vaccine models, and soluble anti-fungal mediators are assayed in fungal killing tests.
Genetic perturbation in model organisms
Drosophila genetics is used to dissect Toll, ubiquitin and eicosanoid pathways controlling AMP production. Teleost models are used to study beta-defensin function in mucosal immunity.
CRISPR-based functional genomics
CRISPR knockout, knock-in and overexpression are applied to test causality of AMP genes and regulators in GO:0061844. These approaches complement biochemical assays and enable high-throughput screening of AMP pathways.
How CRISPR Can Be Used to Study GO:0061844 antimicrobial humoral immune response mediated by antimicrobial peptide
Knockout
CRISPR knockout of AMP genes or their regulators is used to test whether they are required for antimicrobial humoral immunity. For example, knocking out Toll or MyD88 in Drosophila abolishes AMP induction. In mammalian cells, knockout of CAMP or DEFB genes can reduce microbial killing in body-fluid assays.
Point Mutation
Point mutations can be introduced into AMP genes to dissect residues required for antimicrobial activity or secretion. This is valuable for beta-defensin structure-function studies in teleosts and for bactenecin 5 variants in vaccine models.
Knock-in
Tagged knock-in of AMP genes allows tracking of peptide localization and secretion in vivo. This approach is useful in Drosophila to monitor AMP expression downstream of Toll and ubiquitin signaling.
Overexpression
Overexpression of AMPs such as bactenecin 5 can be used to test whether increased peptide levels enhance protection or modulate immunity in vaccine and infection models. Overexpression in epithelial cells can also model the upregulated AMP state seen in allergic airway disease.
How EDITGENE Supports antimicrobial humoral immune response mediated by antimicrobial peptide Research
Researchers studying antimicrobial humoral immune response mediated by antimicrobial peptide-related genes often need to determine whether a candidate gene is causally involved in microbial killing, immune regulation or disease progression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell and animal models for GO:0061844 research.
Contact EDITGENE today to design your custom CRISPR model for antimicrobial humoral immune response mediated by antimicrobial peptide research.
Frequently Asked Questions About antimicrobial humoral immune response mediated by antimicrobial peptide
What is GO:0061844?
GO:0061844 is the Gene Ontology term for antimicrobial humoral immune response mediated by antimicrobial peptide, defined as an immune response against microbes mediated by anti-microbial peptides in body fluid.
What genes are involved in antimicrobial humoral immune response mediated by antimicrobial peptide?
Key genes include DEFB4A, DEFB1, CAMP, bactenecin 5, Drosomycin, Cecropin, Attacin, Toll, MyD88 and NF-kB family members.
How do antimicrobial peptides work in humoral immunity?
AMPs are secreted into body fluids where they directly damage or neutralize microbes, acting as soluble effectors of innate humoral immunity.
Is GO:0061844 conserved across species?
Yes, AMP-mediated humoral immunity is found in insects, teleost fish and mammals, making comparative studies feasible.
What diseases are linked to antimicrobial humoral immune response mediated by antimicrobial peptide?
It has been linked to allergic rhinitis and asthma progression, mycobacterial vaccine responses, HIV-1 restriction and fungal infections.
How can CRISPR be used to study GO:0061844?
CRISPR knockout, knock-in, point mutation and overexpression can test the causal role of AMP genes and regulators in this process.
What model organisms are used to study antimicrobial humoral immunity?
Drosophila, teleost fish and mammalian cell and animal models are commonly used.
What is the role of neutrophils in GO:0061844?
Neutrophils are major sources of AMPs and their antimicrobial responses are upregulated in allergic airway disease progression.
How is AMP gene expression regulated?
Toll, NF-kB, ubiquitin and eicosanoid signaling pathways regulate AMP gene expression in insects and mammals.
What methods are used to measure antimicrobial humoral immunity?
RNA-seq, qPCR, antimicrobial killing assays, CRISPR perturbation and Drosophila genetics are commonly used.
Conclusion
GO:0061844 captures a fundamental and evolutionarily conserved arm of innate humoral immunity in which antimicrobial peptides in body fluids defend against microbial threats. Its relevance spans allergic airway disease, mycobacterial immunity, antiviral restriction and fungal defense, making it a high-value target for functional genomics. CRISPR-based knockout, knock-in, point-mutation and overexpression models, combined with transcriptomics and antimicrobial assays, provide a rigorous path to dissect the causal roles of AMP genes and their regulators in this process.
References
- 1. Li L et al.. 2022. Upregulated antimicrobial immune response mediated by neutrophils in the development from allergic rhinitis to asthma.. Front Immunol 13:1026121 PMID: 36569909
- 2. Dellière S et al.. 2020. Soluble mediators in anti-fungal immunity.. Curr Opin Microbiol 58:24-31 PMID: 32604018
- 3. Das S et al.. 2022. β-Defensin: An adroit saviour in teleosts.. Fish Shellfish Immunol 123:417-430 PMID: 35331882
- 4. Murugaiah V et al.. 2021. Innate Immune Response Against HIV-1.. Adv Exp Med Biol 1313:23-58 PMID: 34661890
- 5. Aalto AL et al.. 2024. Ubiquitin signalling in Drosophila innate immune responses.. FEBS J 291(20):4397-4413 PMID: 38069549
- 6. Munshi T et al.. 2020. The Antimicrobial Peptide, Bactenecin 5, Supports Cell-Mediated but Not Humoral Immunity in the Context of a Mycobacterial Antigen Vaccine Model.. Antibiotics (Basel) 9(12) PMID: 33352656
- 7. Shafeeq T et al.. 2018. Toll immune signal activates cellular immune response via eicosanoids.. Dev Comp Immunol 84:408-419 PMID: 29577956
- 8. Liu XM et al.. 2018. [Progress in innate immunity-related genes in insects].. Yi Chuan 40(6):451-466 PMID: 29959118
